These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8882200)

  • 1. Vaccination against hepatitis B virus in highly endemic areas: waning vaccine-induced immunity and the need for booster doses.
    Edmunds WJ; Medley GF; Nokes DJ
    Trans R Soc Trop Med Hyg; 1996; 90(4):436-40. PubMed ID: 8882200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a change in the epidemiology of hepatitis B virus infection after nearly two decades of universal hepatitis B vaccination in South Africa.
    Amponsah-Dacosta E; Lebelo RL; Rakgole JN; Burnett RJ; Selabe SG; Mphahlele MJ
    J Med Virol; 2014 Jun; 86(6):918-24. PubMed ID: 24615635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From infancy and beyond… ensuring a lifetime of hepatitis B virus (HBV) vaccine-induced immunity.
    Osiowy C
    Hum Vaccin Immunother; 2018; 14(8):2093-2097. PubMed ID: 29641290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Waning immunity and booster responses in nursing and medical technology students who had received plasma-derived or recombinant hepatitis B vaccine during infancy.
    Lin CC; Yang CY; Shih CT; Chen BH; Huang YL
    Am J Infect Control; 2011 Jun; 39(5):408-414. PubMed ID: 21255876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B infection control in Colombian Amazon after 15 years of hepatitis B vaccination. Effectiveness of birth dose and current prevalence.
    Garcia D; Porras A; Rico Mendoza A; Alvis N; Navas MC; De La Hoz F; De Neira M; Osorio E; Valderrama JF
    Vaccine; 2018 May; 36(19):2721-2726. PubMed ID: 29609968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
    Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
    Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
    He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
    Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and long term anamnestic response to HBV booster dose among fully vaccinated Egyptian children during infancy.
    Salama II; Sami SM; Said ZN; Salama SI; Rabah TM; Abdel-Latif GA; Elmosalami DM; Saleh RM; Abdel Mohsin AM; Metwally AM; Hassanin AI; Emam HM; Hemida SA; Elserougy SM; Shaaban FA; Fouad WA; Mohsen A; El-Sayed MH
    Vaccine; 2018 Apr; 36(15):2005-2011. PubMed ID: 29530634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
    Kao JH
    Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F; Perez L; de Neira M; Hall AJ
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B vaccination: a completed schedule enough to control HBV lifelong? Milan, Italy, 17-18 November 2011.
    FitzSimons D; Hendrickx G; Vorsters A; Van Damme P
    Vaccine; 2013 Jan; 31(4):584-90. PubMed ID: 23142301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
    Zhu CL; Liu P; Chen T; Ni Z; Lu LL; Huang F; Lu J; Sun Z; Qu C
    Vaccine; 2011 Oct; 29(44):7835-41. PubMed ID: 21816197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana.
    Mahoney FJ; Lawrence M; Scott C; Le Q; Lambert S; Farley TA
    Pediatrics; 1995 Dec; 96(6):1113-6. PubMed ID: 7491231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune persistence after hepatitis B vaccination in infancy - Fact or fancy?
    Lao TT
    Hum Vaccin Immunother; 2016 May; 12(5):1172-6. PubMed ID: 26810256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
    Wang Y; Chen T; Lu LL; Wang M; Wang D; Yao H; Fan C; Qi J; Zhang Y; Qu C
    Vaccine; 2017 Feb; 35(7):1064-1070. PubMed ID: 28069363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.